PeterJSiekmeierMDMS

PubMed

• 1 citations
  An in Silico, Biomarker-Based Method for the Evaluation of Virtual Neuropsychiatric Drug Effects.
  Peter J. Siekmeier
  Neural Computation. 2017-03-23
• 7 citations
  Computational modeling of psychiatric illnesses via well-defined neurophysiological and neurocognitive biomarkers.
  Peter J. Siekmeier
  Neuroscience and Biobehavioral Reviews. 2015-10-01
• 4 citations
  Dopaminergic Contributions to Hippocampal Pathophysiology in Schizophrenia: A Computational Study
  Peter J. Siekmeier, David P. vanMaanen
  Neuropsychopharmacology. 2014-01-28

Abstracts/Posters

• Increased beta-gamma power ratio in MEG auditory steady-state responses: A potential biomarker for chronic schizophrenia
  Siekmeier, P.J., Stufflebeam, S.M., Spencer, S.K., Hamalainen, M., McCarley, R., Neuropsychopharmacology, 12/10/2014
• Treatment of dopaminergic dysfunction in schizophrenia using non-dopaminergic mechanisms: A computational modeling approach
  Siekmeier, P.J. and vanMaanen, D.P., Neuropsychopharmacology, 12/9/2013
• Novel EEG biomarkers for the a priori identification of responders to the experimental antipsychotic agen pomaglumetad methionil
  Siekmeier, P.J. and Lowen, S.B., Neuropsychopharmacology, Florida, 12/11/2019
• Computational modeling of hippocampus in schizophrenia and novel antipsychotic development
  Siekmeier, P.J. and vanMaanen, D.P., Neuropsychopharmacology, 12/3/2012
• Computational modeling of prefrontal cortex neuropathology in schizophrenia
  Shaskan, N. K., Woo, T., Siekmeier, P., and vanMaanen, D., Neuroscience Meeting Planner, Society for Neuroscience, New Orleans, LA, 10/14/2012
• Relating neuropathological findings in hippocampus to schizophrenic symptomatology: A computational modeling approach
  Siekmeier, P.J. and VanMaanen, D., Biological Psychiatry, 5/5/2012
• Computational approach to understanding prefrontal cortex circuit deficits in schizophrenia
  Siekmeier, P.J. and Woo, W., 3rd Biennial Schizophrenia International Research Society Convention, Florence, Italy, 4/15/2012
• Modeling GABA Alterations in Schizophrenia
  Vierling-Claasen, D., Siekmeier, P., Stufflebeam, S., Kopell, N., Schizophrenia Research, 6/21/2008
• Altered GABA receptor dynamics explains abnormal rhythmic auditory neuromagnetic response in schizophrenia
  Stufflebeam, S., Vierling-Claassen, D., Lin, F-H., Siekmeier, P., Hamalainen, M., Kopell, N., McCarley, R., Proceedings of the 15 th International Conference on Biomagnetism, Vancouver, British Columbia, Canada, 8/22/2006
• The use of an attractor neural network model to explore normal brain function and the pathogenesis of schizophrenia
  Siekmeier, P.J., Yale Journal of Biology and Medicine, 5/1/1997
• Join now to see all

Other

• Apparatuses and methods for identification and treatment of patients responsive to antipsychotic agent therapy. WO Patent Application No. PCT/US2020/49194. 
  P. J. Siekmeier, S.B. Lowen, and J.T. Coyle
  https://patentimages.storage.googleapis.com/eb/a4/a9/7fbc05f4a335c2/WO2021046215A1.pdf
  9/3/2020
• Method of increasing cognitive function with glutamate receptor agonist. WO Patent Application No. PCT/US2020/49283. 
  P. Siekmeier, S. Lowen, and J.T. Coyle.
  https://patentimages.storage.googleapis.com/d0/97/bc/3b8faf78d14b41/WO2021046273A1.pdf
  9/3/2020
• Systems and methods for modeling and predicting effective treatments for schizophrenia and other disorders. U.S. Patent No. 10,720,242. 
  P. Siekmeier, McLean Hospital assignee
  https://patentimages.storage.googleapis.com/60/b7/7c/a9d737b20ebfbe/US10720242.pdf
  7/21/2020
• Methods and systems for drug screening and computational modeling based on biologically realistic neurons. U.S. Patent No. 7,945,392. 
  P. Siekmeier and S. Matthysse
  https://patentimages.storage.googleapis.com/34/1c/ec/c64279efed5185/US7945392.pdf
  5/17/2011
• Join now to see all